625 related articles for article (PubMed ID: 29589283)
21. Neurons with Cat's Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions.
De Giorgi F; Abdul-Shukkoor MB; Kashyrina M; Largitte LA; De Nuccio F; Kauffmann B; Lends A; Laferrière F; Bonhommeau S; Lofrumento DD; Bousset L; Bezard E; Buffeteau T; Loquet A; Ichas F
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327628
[TBL] [Abstract][Full Text] [Related]
22. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
[TBL] [Abstract][Full Text] [Related]
23. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.
Shahnawaz M; Mukherjee A; Pritzkow S; Mendez N; Rabadia P; Liu X; Hu B; Schmeichel A; Singer W; Wu G; Tsai AL; Shirani H; Nilsson KPR; Low PA; Soto C
Nature; 2020 Feb; 578(7794):273-277. PubMed ID: 32025029
[TBL] [Abstract][Full Text] [Related]
24. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
25. MSA prions exhibit remarkable stability and resistance to inactivation.
Woerman AL; Kazmi SA; Patel S; Freyman Y; Oehler A; Aoyagi A; Mordes DA; Halliday GM; Middleton LT; Gentleman SM; Olson SH; Prusiner SB
Acta Neuropathol; 2018 Jan; 135(1):49-63. PubMed ID: 28849371
[TBL] [Abstract][Full Text] [Related]
26. Structural and Functional Insights into α-Synuclein Fibril Polymorphism.
Mehra S; Gadhe L; Bera R; Sawner AS; Maji SK
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680054
[TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
[TBL] [Abstract][Full Text] [Related]
28. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
[TBL] [Abstract][Full Text] [Related]
29. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
30. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
Peelaerts W; Baekelandt V
J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
[TBL] [Abstract][Full Text] [Related]
31. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
Kurapova R; Chouliaras L; O'Brien JT
Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
34. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
[TBL] [Abstract][Full Text] [Related]
35. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
Valdinocci D; Grant GD; Dickson TC; Pountney DL
Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
[TBL] [Abstract][Full Text] [Related]
36. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
38. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
[TBL] [Abstract][Full Text] [Related]
39. Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein.
Sengupta U; Puangmalai N; Bhatt N; Garcia S; Zhao Y; Kayed R
Mol Neurobiol; 2020 Jun; 57(6):2741-2765. PubMed ID: 32350746
[TBL] [Abstract][Full Text] [Related]
40. Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy.
Lövestam S; Schweighauser M; Matsubara T; Murayama S; Tomita T; Ando T; Hasegawa K; Yoshida M; Tarutani A; Hasegawa M; Goedert M; Scheres SHW
FEBS Open Bio; 2021 Apr; 11(4):999-1013. PubMed ID: 33548114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
